Literature DB >> 23290374

Evidence-based clinical practice guidelines for managing depression in persons living with HIV.

Michael V Relf1, Shelly Eisbach, Kayj Nash Okine, Terry Ward.   

Abstract

Depressive symptoms and depression are prevalent among persons living with HIV (PLWH). Depression among PLWH is associated with a lower quality of life, reduced adherence to antiretroviral treatment, poorer self-care, worsened treatment outcomes, greater impairment in social and vocational functioning, and increased social isolation. Assessment of depression in PLWH is critical to facilitate referral and management. Fortunately, two simple screening questions can be used to assess for depression, and evidence supports the effective management of depression for PLWH. First-line treatment regimens for depression include selective serotonin reuptake inhibitors (SSRIs), cognitive behavioral therapy (CBT), or a combination of SSRI and CBT. This paper examines the contemporary evidence related to depression in the context of HIV infection. A case study has been included to illustrate an application of evidence-based treatment interventions recommended for clinical practice.
Copyright © 2013 Association of Nurses in AIDS Care. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23290374     DOI: 10.1016/j.jana.2012.05.007

Source DB:  PubMed          Journal:  J Assoc Nurses AIDS Care        ISSN: 1055-3290            Impact factor:   1.354


  7 in total

1.  Predictors of medication adherence among HIV-positive women in North America.

Authors:  Lynda A Tyer-Viola; Inge B Corless; Alison Webel; Paula Reid; Kathleen M Sullivan; Patrice Nichols
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2014-02-06

2.  Associations between Depressive Symptomatology and Neurocognitive Impairment in HIV/AIDS.

Authors:  Sarah Tymchuk; Daniela Gomez; Noshin Koenig; M John Gill; Esther Fujiwara; Christopher Power
Journal:  Can J Psychiatry       Date:  2017-12-11       Impact factor: 4.356

3.  The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults.

Authors:  Lucette A Cysique; Nadene Dermody; Andrew Carr; Bruce J Brew; Maree Teesson
Journal:  J Neurovirol       Date:  2015-08-25       Impact factor: 2.643

4.  Clinical characteristics of abnormal savda syndrome type in human immunodeficiency virus infection and acquired immune deficiency syndrome patients: A cross-sectional investigation in Xinjiang, China.

Authors:  Mi-ji-ti Peierdun; Wen-xian Liu; Ai-ze-zi Renaguli; Amat Nurmuhammat; Xiao-chun Li; Ka-ha-er Gulibaier; Wu-la-mu Ainivaer; Upur Halmurat
Journal:  Chin J Integr Med       Date:  2015-03-06       Impact factor: 2.626

5.  Dataset of cognitive behavioral intervention for persons living with HIV in China: A randomized pilot trial.

Authors:  Shuyu Han; Yan Hu; Zheng Zhu; Bei Wu
Journal:  Data Brief       Date:  2020-03-31

6.  The impact of HIV/AIDS on compliance with antidepressant treatment in major depressive disorder: A prospective study in a South African private healthcare cohort.

Authors:  Francois N Slabbert; Brian H Harvey; Christiaan B Brink; Martie S Lubbe
Journal:  AIDS Res Ther       Date:  2015-04-14       Impact factor: 2.250

7.  An Internet-based self-help intervention for people with HIV and depressive symptoms: study protocol for a randomized controlled trial.

Authors:  Sanne van Luenen; Vivian Kraaij; Philip Spinhoven; Nadia Garnefski
Journal:  Trials       Date:  2016-03-31       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.